Leading the fight against lung disease through research
We have a long history of research into respiratory disease.
Lung disease is responsible for around a fifth of deaths in the UK every year. We know that only medical research has the power to end the devastating lung conditions that affect millions of people, and to save, prolong and improve lives.
Every year our world-class research looks for ways to prevent, treat and cure a wide range of lung conditions. According to figures from the UK Clinical Research Collaboration, research into respiratory disease is significantly underfunded in relation to the effect it has on so many lives.
For example, money spent on research into lung conditions falls below that spent on conditions such as arthritis, osteoporosis and diabetes. But the number of years lost due to ill health, disability or early death from respiratory disease is far greater.
It’s really clear that we have an essential role to play in providing much-needed research into respiratory conditions.
Making a difference
We want to drive research in areas where we know we can make a real difference to people with lung conditions. For example, a major focus at the moment is mesothelioma, a devastating cancer caused by asbestos exposure.
Mesothelioma kills more than 2,400 people every year in the UK, a figure that is rising and expected to peak later this decade. We’re campaigning for a sustainable research fund for mesothelioma.
Right now, insurance companies pay out millions each year to people who are living with the condition or their bereaved loved ones. But just a fraction of this amount could revolutionise mesothelioma research and provide new treatments. People affected by the condition could live longer, healthier and more productive lives, so less compensation would need to be paid out by the companies.
Our campaign asks insurance companies to contribute more to this type of respiratory research, with the potential for everyone – researchers, people living with mesothelioma, and the companies themselves – to benefit from the result.
Supporting breakthrough researchers
Making sure that young scientists move into respiratory research is essential in the long-term battle against lung disease. They need support in the early stages of their career to help them go on to make future breakthroughs.
We have a great track record of backing exceptional young researchers. Professors Stephen Holgate and Peter Barnes, who received BLF support early in their careers, are now world-renowned research leaders and were recently named by the European Journal of Clinical Investigation as amongst the world’s 100 most influential biomedical scientists in any field.
This is the fight against lung disease – and we’re all in it together. You can make a huge difference by donating to our research today.